Professional Documents
Culture Documents
HAEMATOLOGICAL PROFILE
INTRODUCTION
OBJECTIVES
1.To estimate the proportion of patients with hematological abnormalities as the
manifestation of SLE
The findings in our study was similar to other studies as done by Agrawal et
100
90 al(3) in Central India , Sasidharan et al(1) in kerala and Njoroge et al (4) in
85 Africa.
80
CONCLUSION
35
Hematological manifestation is the second most common presenting
10
manifestation of SLE in people of Barak valley, India. The study concludes that
ARTHRITIS HEMATOLOGICAL ORAL ULCERS ALOPECIA ANA ANTI-DSDNA
treatment of hematological abnormalities is challenging because the treatment
itself can cause undue complication such as Leucopenia due the use of high
Hematological abnormalities were present in 85% cases. doses of steroids or granulocytosis due to infections .
Anemia was the most common finding and detected in 80% of total cases of It is important to take these factors into consideration for disease therapy and
which anemia of chronic disease in 75% and 12.5% each in IDA and AIHA management.
were observed .
BIBLIOGRAPHY
Leucopenia was found in 25% patients and neutrophilia in 10%. 1. HematologicalManifestations of SLE at Initial Presentation: P. K. Sasidharan, M.Bindya, KG.Sajeeth Kumar. ISRN Hematology doi:10.5402/2012/961872
2. Fayyaz A, Igoe A, Kurien BT, et al. Haematological manifestations of lupus. Lupus Science & Medicine 2015;2:e000078. doi:10.1136/lupus-2014-000078
3. Agrawal SR, Tiewsoh I, Rajput A, Jain A. study of clinical andimmunological profile of systemic lupus erythematosus patients from central rural India. printed by
Indian J Allergy Asthma Immunol 2013;27:33-7.
Thrombocytopenia was seen 25% cases 4. Njoroge JW1, Oyoo GO1, Kitonyi G2, Barasa A2, Odhiambo A1 Afr J Rheumatol 2016; 4(2): 57-62
www.postersession.com